[10-06-2021] Changed Dropout layers values

| TRAIN           | tp    | fp  | fn  | #pred | #exp  | P     | R     | F1    |
|-----------------|-------|-----|-----|-------|-------|-------|-------|-------|
|                 |       |     |     |       |       |       |       |       |
| brand           | 1118  | 49  | 40  | 1167  | 1158  | 95.8% | 96.5% | 96.2% |
| drug            | 6915  | 169 | 341 | 7084  | 7256  | 97.6% | 95.3% | 96.4% |
| drug_n          | 332   | 49  | 195 | 381   | 527   | 87.1% | 63.0% | 73.1% |
| group           | 2436  | 334 | 250 | 2770  | 2686  | 87.9% | 90.7% | 89.3% |
|                 |       |     |     |       |       |       |       |       |
| M.avg           | -     | -   | -   | -     | -     | 92.1% | 86.4% | 88.8% |
|                 |       |     |     |       |       |       |       |       |
| m.avg           | 10801 | 601 | 826 | 11402 | 11627 | 94.7% | 92.9% | 93.8% |
| m.avg(no class) | 10938 | 464 | 689 | 11402 | 11627 | 95.9% | 94.1% | 95.0% |


| DEVEL           | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 213  | 46  | 147 | 259   | 360  | 82.2% | 59.2% | 68.8% |
| drug            | 1666 | 162 | 247 | 1828  | 1913 | 91.1% | 87.1% | 89.1% |
| drug_n          | 2    | 25  | 43  | 27    | 45   | 7.4%  | 4.4%  | 5.6%  |
| group           | 538  | 154 | 143 | 692   | 681  | 77.7% | 79.0% | 78.4% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 64.6% | 57.4% | 60.5% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2419 | 387 | 580 | 2806  | 2999 | 86.2% | 80.7% | 83.3% |
| m.avg(no class) | 2514 | 292 | 485 | 2806  | 2999 | 89.6% | 83.8% | 86.6% |


| TEST            | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 191  | 84  | 97  | 275   | 288  | 69.5% | 66.3% | 67.9% |
| drug            | 1766 | 185 | 354 | 1951  | 2120 | 90.5% | 83.3% | 86.8% |
| drug_n          | 4    | 14  | 68  | 18    | 72   | 22.2% | 5.6%  | 8.9%  |
| group           | 554  | 185 | 145 | 739   | 699  | 75.0% | 79.3% | 77.1% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 64.3% | 58.6% | 60.1% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2515 | 468 | 664 | 2983  | 3179 | 84.3% | 79.1% | 81.6% |
| m.avg(no class) | 2659 | 324 | 520 | 2983  | 3179 | 89.1% | 83.6% | 86.3% |


[09-06-2021] Changed class embeddings checking order (in order to prioritize drug_n)

| TRAIN           | tp    | fp  | fn  | #pred | #exp  | P     | R     | F1    |
|-----------------|-------|-----|-----|-------|-------|-------|-------|-------|
|                 |       |     |     |       |       |       |       |       |
| brand           | 1136  | 22  | 22  | 1158  | 1158  | 98.1% | 98.1% | 98.1% |
| drug            | 6959  | 70  | 297 | 7029  | 7256  | 99.0% | 95.9% | 97.4% |
| drug_n          | 397   | 46  | 130 | 443   | 527   | 89.6% | 75.3% | 81.9% |
| group           | 2500  | 226 | 186 | 2726  | 2686  | 91.7% | 93.1% | 92.4% |
|                 |       |     |     |       |       |       |       |       |
| M.avg           | -     | -   | -   | -     | -     | 94.6% | 90.6% | 92.4% |
|                 |       |     |     |       |       |       |       |       |
| m.avg           | 10992 | 364 | 635 | 11356 | 11627 | 96.8% | 94.5% | 95.7% |
| m.avg(no class) | 11072 | 284 | 555 | 11356 | 11627 | 97.5% | 95.2% | 96.3% |


| DEVEL           | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 203  | 52  | 157 | 255   | 360  | 79.6% | 56.4% | 66.0% |
| drug            | 1626 | 152 | 287 | 1778  | 1913 | 91.5% | 85.0% | 88.1% |
| drug_n          | 4    | 15  | 41  | 19    | 45   | 21.1% | 8.9%  | 12.5% |
| group           | 536  | 160 | 145 | 696   | 681  | 77.0% | 78.7% | 77.9% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 67.3% | 57.2% | 61.1% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2369 | 379 | 630 | 2748  | 2999 | 86.2% | 79.0% | 82.4% |
| m.avg(no class) | 2465 | 283 | 534 | 2748  | 2999 | 89.7% | 82.2% | 85.8% |


| TEST            | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 184  | 63  | 104 | 247   | 288  | 74.5% | 63.9% | 68.8% |
| drug            | 1722 | 200 | 398 | 1922  | 2120 | 89.6% | 81.2% | 85.2% |
| drug_n          | 3    | 15  | 69  | 18    | 72   | 16.7% | 4.2%  | 6.7%  |
| group           | 561  | 202 | 138 | 763   | 699  | 73.5% | 80.3% | 76.7% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 63.6% | 57.4% | 59.4% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2470 | 481 | 709 | 2951  | 3179 | 83.7% | 77.7% | 80.6% |
| m.avg(no class) | 2603 | 348 | 576 | 2951  | 3179 | 88.2% | 81.9% | 84.9% |


[09-06-2021] Added pretrained Embbeding Matrix, and class suff. pref. and contain. embeddings

| TRAIN           | tp    | fp  | fn  | #pred | #exp  | P     | R     | F1    |
|-----------------|-------|-----|-----|-------|-------|-------|-------|-------|
|                 |       |     |     |       |       |       |       |       |
| brand           | 1135  | 23  | 23  | 1158  | 1158  | 98.0% | 98.0% | 98.0% |
| drug            | 6959  | 69  | 297 | 7028  | 7256  | 99.0% | 95.9% | 97.4% |
| drug_n          | 392   | 45  | 135 | 437   | 527   | 89.7% | 74.4% | 81.3% |
| group           | 2505  | 233 | 181 | 2738  | 2686  | 91.5% | 93.3% | 92.4% |
|                 |       |     |     |       |       |       |       |       |
| M.avg           | -     | -   | -   | -     | -     | 94.6% | 90.4% | 92.3% |
|                 |       |     |     |       |       |       |       |       |
| m.avg           | 10991 | 370 | 636 | 11361 | 11627 | 96.7% | 94.5% | 95.6% |
| m.avg(no class) | 11075 | 286 | 552 | 11361 | 11627 | 97.5% | 95.3% | 96.4% |

| DEVEL           | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 211  | 58  | 149 | 269   | 360  | 78.4% | 58.6% | 67.1% |
| drug            | 1623 | 148 | 290 | 1771  | 1913 | 91.6% | 84.8% | 88.1% |
| drug_n          | 4    | 15  | 41  | 19    | 45   | 21.1% | 8.9%  | 12.5% |
| group           | 539  | 160 | 142 | 699   | 681  | 77.1% | 79.1% | 78.1% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 67.1% | 57.9% | 61.5% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2377 | 381 | 622 | 2758  | 2999 | 86.2% | 79.3% | 82.6% |
| m.avg(no class) | 2472 | 286 | 527 | 2758  | 2999 | 89.6% | 82.4% | 85.9% |

| TEST            | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 185  | 63  | 103 | 248   | 288  | 74.6% | 64.2% | 69.0% |
| drug            | 1721 | 202 | 399 | 1923  | 2120 | 89.5% | 81.2% | 85.1% |
| drug_n          | 2    | 15  | 70  | 17    | 72   | 11.8% | 2.8%  | 4.5%  |
| group           | 560  | 209 | 139 | 769   | 699  | 72.8% | 80.1% | 76.3% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 62.2% | 57.1% | 58.7% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2468 | 489 | 711 | 2957  | 3179 | 83.5% | 77.6% | 80.4% |
| m.avg(no class) | 2605 | 352 | 574 | 2957  | 3179 | 88.1% | 81.9% | 84.9% |


[09-06-2021] Added prevword and nextword embedding.

| TRAIN           | tp    | fp  | fn  | #pred | #exp  | P     | R     | F1    |
|-----------------|-------|-----|-----|-------|-------|-------|-------|-------|
|                 |       |     |     |       |       |       |       |       |
| brand           | 1140  | 13  | 18  | 1153  | 1158  | 98.9% | 98.4% | 98.7% |
| drug            | 6996  | 51  | 260 | 7047  | 7256  | 99.3% | 96.4% | 97.8% |
| drug_n          | 424   | 57  | 103 | 481   | 527   | 88.1% | 80.5% | 84.1% |
| group           | 2536  | 128 | 150 | 2664  | 2686  | 95.2% | 94.4% | 94.8% |
|                 |       |     |     |       |       |       |       |       |
| M.avg           | -     | -   | -   | -     | -     | 95.4% | 92.4% | 93.9% |
|                 |       |     |     |       |       |       |       |       |
| m.avg           | 11096 | 249 | 531 | 11345 | 11627 | 97.8% | 95.4% | 96.6% |
| m.avg(no class) | 11127 | 218 | 500 | 11345 | 11627 | 98.1% | 95.7% | 96.9% |

| DEVEL           | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 156  | 35  | 204 | 191   | 360  | 81.7% | 43.3% | 56.6% |
| drug            | 1621 | 193 | 292 | 1814  | 1913 | 89.4% | 84.7% | 87.0% |
| drug_n          | 12   | 87  | 33  | 99    | 45   | 12.1% | 26.7% | 16.7% |
| group           | 530  | 132 | 151 | 662   | 681  | 80.1% | 77.8% | 78.9% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 65.8% | 58.1% | 59.8% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2319 | 447 | 680 | 2766  | 2999 | 83.8% | 77.3% | 80.5% |
| m.avg(no class) | 2437 | 329 | 562 | 2766  | 2999 | 88.1% | 81.3% | 84.5% |

| TEST            | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
| brand           | 124  | 33  | 164 | 157   | 288  | 79.0% | 43.1% | 55.7% |
| drug            | 1751 | 186 | 369 | 1937  | 2120 | 90.4% | 82.6% | 86.3% |
| drug_n          | 6    | 105 | 66  | 111   | 72   | 5.4%  | 8.3%  | 6.6%  |
| group           | 556  | 181 | 143 | 737   | 699  | 75.4% | 79.5% | 77.4% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 62.6% | 53.4% | 56.5% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2437 | 505 | 742 | 2942  | 3179 | 82.8% | 76.7% | 79.6% |
| m.avg(no class) | 2593 | 349 | 586 | 2942  | 3179 | 88.1% | 81.6% | 84.7% |

[08-06-2021] Added suf, pref and pos embedding. Changed the LSTM units to 32

| TRAIN           | tp    | fp  | fn  | #pred | #exp  | P     | R     | F1    |
|-----------------|-------|-----|-----|-------|-------|-------|-------|-------|
|                 |       |     |     |       |       |       |       |       |
| brand           | 1124  | 16  | 34  | 1140  | 1158  | 98.6% | 97.1% | 97.8% |
| drug            | 6929  | 146 | 327 | 7075  | 7256  | 97.9% | 95.5% | 96.7% |
| drug_n          | 390   | 69  | 137 | 459   | 527   | 85.0% | 74.0% | 79.1% |
| group           | 2414  | 220 | 272 | 2634  | 2686  | 91.6% | 89.9% | 90.8% |
|                 |       |     |     |       |       |       |       |       |
| M.avg           | -     | -   | -   | -     | -     | 93.3% | 89.1% | 91.1% |
|                 |       |     |     |       |       |       |       |       |
| m.avg           | 10857 | 451 | 770 | 11308 | 11627 | 96.0% | 93.4% | 94.7% |
| m.avg(no class) | 10913 | 395 | 714 | 11308 | 11627 | 96.5% | 93.9% | 95.2% |

| DEVEL           | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 122  | 28  | 238 | 150   | 360  | 81.3% | 33.9% | 47.8% |
| drug            | 1593 | 149 | 320 | 1742  | 1913 | 91.4% | 83.3% | 87.2% |
| drug_n          | 9    | 7   | 36  | 16    | 45   | 56.2% | 20.0% | 29.5% |
| group           | 498  | 156 | 183 | 654   | 681  | 76.1% | 73.1% | 74.6% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 76.3% | 52.6% | 59.8% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2222 | 340 | 777 | 2562  | 2999 | 86.7% | 74.1% | 79.9% |
| m.avg(no class) | 2289 | 273 | 710 | 2562  | 2999 | 89.3% | 76.3% | 82.3% |


| TEST            | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 97   | 23  | 191 | 120   | 288  | 80.8% | 33.7% | 47.5% |
| drug            | 1733 | 158 | 387 | 1891  | 2120 | 91.6% | 81.7% | 86.4% |
| drug_n          | 3    | 13  | 69  | 16    | 72   | 18.8% | 4.2%  | 6.8%  |
| group           | 521  | 183 | 178 | 704   | 699  | 74.0% | 74.5% | 74.3% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 66.3% | 48.5% | 53.8% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2354 | 377 | 825 | 2731  | 3179 | 86.2% | 74.0% | 79.7% |
| m.avg(no class) | 2451 | 280 | 728 | 2731  | 3179 | 89.7% | 77.1% | 82.9% |

[08-06-2021] Adding another LSTM after the BiLSTm do not improve the results. Then, we reject this iteration

[08-06-2021] When running with the first experimentation. We use a Input + Embedding + BiLSTM + TimeDistributed for 20 epochs

|      TRAIN      	|   tp  	|  fp 	|  fn  	| #pred 	|  #exp 	|   P   	|   R   	|   F1  	|
|:---------------:	|:-----:	|:---:	|:----:	|:-----:	|:-----:	|:-----:	|:-----:	|:-----:	|
|        -        	|   -   	|  -  	|   -  	|   -   	|   -   	|   -   	|   -   	|   -   	|
|      brand      	|  1141 	|  14 	|  17  	|  1155 	|  1158 	| 98.8% 	| 98.5% 	| 98.7% 	|
|       drug      	|  6991 	|  77 	|  265 	|  7068 	|  7256 	| 98.9% 	| 96.3% 	| 97.6% 	|
|      drug_n     	|  418  	|  73 	|  109 	|  491  	|  527  	| 85.1% 	| 79.3% 	| 82.1% 	|
|      group      	|  2527 	| 115 	|  159 	|  2642 	|  2686 	| 95.6% 	| 94.1% 	| 94.9% 	|
|        -        	|  428  	| 190 	|  422 	|  618  	|  850  	| 69.3% 	| 50.4% 	| 58.3% 	|
|      M.avg      	|   -   	|  -  	|   -  	|   -   	|   -   	| 94.6% 	| 92.1% 	| 93.3% 	|
|        -        	|  1949 	| 247 	| 1050 	|  2196 	|  2999 	| 88.8% 	| 65.0% 	| 75.0% 	|
|      m.avg      	| 11077 	| 279 	|  550 	| 11356 	| 11627 	| 97.5% 	| 95.3% 	| 96.4% 	|
| m.avg(no class) 	| 11101 	| 255 	|  526 	| 11356 	| 11627 	| 97.8% 	| 95.5% 	| 96.6% 	|

|      DEVEL      	|  tp  	|  fp 	|  fn  	| #pred 	| #exp 	|    P   	|   R   	|   F1  	|
|:---------------:	|:----:	|:---:	|:----:	|:-----:	|:----:	|:------:	|:-----:	|:-----:	|
|        -        	|   -  	|  -  	|   -  	|   -   	|   -  	|    -   	|   -   	|   -   	|
|      brand      	|  45  	|  0  	|  315 	|   45  	|  360 	| 100.0% 	| 12.5% 	| 22.2% 	|
|       drug      	| 1367 	| 138 	|  546 	|  1505 	| 1913 	|  90.8% 	| 71.5% 	| 80.0% 	|
|      drug_n     	|   6  	|  10 	|  39  	|   16  	|  45  	|  37.5% 	| 13.3% 	| 19.7% 	|
|      group      	|  491 	| 139 	|  190 	|  630  	|  681 	|  77.9% 	| 72.1% 	| 74.9% 	|
|        -        	|   -  	|  -  	|   -  	|   -   	|   -  	|    -   	|   -   	|   -   	|
|      M.avg      	|   -  	|  -  	|   -  	|   -   	|   -  	|  76.6% 	| 42.3% 	| 49.2% 	|
|        -        	|  428 	| 190 	|  422 	|  618  	|  850 	|  69.3% 	| 50.4% 	| 58.3% 	|
|      m.avg      	| 1909 	| 287 	| 1090 	|  2196 	| 2999 	|  86.9% 	| 63.7% 	| 73.5% 	|
| m.avg(no class) 	| 1949 	| 247 	| 1050 	|  2196 	| 2999 	|  88.8% 	| 65.0% 	| 75.0% 	|

|       TEST      	|  tp  	|  fp 	|  fn  	| #pred 	| #exp 	|   P   	|   R   	|   F1  	|
|:---------------:	|:----:	|:---:	|:----:	|:-----:	|:----:	|:-----:	|:-----:	|:-----:	|
|        -        	|   -  	|  -  	|   -  	|   -   	|   -  	|   -   	|   -   	|   -   	|
|      brand      	|  80  	|  5  	|  208 	|   85  	|  288 	| 94.1% 	| 27.8% 	| 42.9% 	|
|       drug      	| 1547 	| 117 	|  573 	|  1664 	| 2120 	| 93.0% 	| 73.0% 	| 81.8% 	|
|      drug_n     	|   0  	|  12 	|  72  	|   12  	|  72  	|  0.0% 	|  0.0% 	|  0.0% 	|
|      group      	|  542 	| 188 	|  157 	|  730  	|  699 	| 74.2% 	| 77.5% 	| 75.9% 	|
|        -        	|   -  	|  -  	|   -  	|   -   	|   -  	|   -   	|   -   	|   -   	|
|      M.avg      	|   -  	|  -  	|   -  	|   -   	|   -  	| 65.3% 	| 44.6% 	| 50.1% 	|
|        -        	|  428 	| 190 	|  422 	|  618  	|  850 	| 69.3% 	| 50.4% 	| 58.3% 	|
|      m.avg      	| 2169 	| 322 	| 1010 	|  2491 	| 3179 	| 87.1% 	| 68.2% 	| 76.5% 	|
| m.avg(no class) 	| 2235 	| 256 	|  944 	|  2491 	| 3179 	| 89.7% 	| 70.3% 	| 78.8% 	|


(created using: https://www.tablesgenerator.com/markdown_tables)
